Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1621888

This article is part of the Research TopicRole of Genotoxic Stressors and Survival / Metabolic Pathways in Inflammatory Activation and Cell Recruitment in Cardiovascular DiseasesView all articles

Changes in monocyte subsets are associated with an increased risk of AAA and are surrogate markers for AAA morphology in patients with late-stage disease

Provisionally accepted
Bianca  HamannBianca Hamann1Anna  KlimovaAnna Klimova2Marvin  KapallaMarvin Kapalla1David  M PoitzDavid M Poitz3Albert  BuschAlbert Busch1Henning  MorawietzHenning Morawietz4Christian  ReepsChristian Reeps1Anja  HofmannAnja Hofmann1*
  • 1Division of Vascular and Endovascular Surgery, Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Medical Faculty Carl Gustav Carus, Dresden, Germany
  • 2Institute for Medical Informatics and Biometry, Faculty of Medicine, TUD Dresden University of Technology, Dresden, Germany
  • 3Institute for Clinical Chemistry and Laboratory Medicine; University Hospital and Medical Faculty Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
  • 4Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital and Medical Faculty Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany

The final, formatted version of the article will be published soon.

Introduction: Monocytes play a role in pathology of abdominal aortic aneurysm (AAA) and can display an immunophenotypic heterogeneity. Alterations in monocyte subsets are associated with cardiovascular risk, but their profile in AAA is poorly understood. Aim: We aimed to comprehensively define associations of monocyte phenotypes with AAA risk and AAA morphology. Methods: Monocyte subsets (CD14++CD16-; CD14++/CD16+; CD14+/CD16++) were analyzed in an observational study in patients with AAA (n=33) and varicose veins (n=33) using flow cytometry. Results: Classical monocytes were 3 % lower (P=0.001) in AAA, while intermediate and non-classical monocytes were 1.8 (P=0.019) and 1.9-fold (P=0.025) higher in AAA, respectively. The differences remained significant after adjusting for age, sex and peripheral artery disease. A lowering of classical monocytes (OR: 0.73, P=0.002) and increases in intermediate (OR: 1.41, P=0.006) and non-classical monocytes (OR: 1.54, P=0.030) were associated with a higher risk of AAA. Non-classical monocytes showed an inverse correlation with AAA diameter (rP =-0.64, P=0.001) and AAA volume (rP =-0.50, P=0.003). Conclusion: The present study revealed age-and sex-independent shifts in monocytes, all of which were associated with risk of AAA disease. Non-classical monocytes were inversely correlated with AAA diameter and volume and thus may be surrogate markers for AAA morphology. Non-standard abbreviations and acronyms AAA, abdominal aortic aneurysm; ACE, angiotensin-converting enzyme; ARBs, angiotensin receptor blocker; ASA, acetylsalicylic acid; BMI, body mass index; CAD, coronary artery disease; CAS, carotid artery stenosis; CCB, calcium channel blocker; CVD, cardiovascular disease; Hb, hemoglobin; HDL, high-density lipoprotein cholesterol; HF, heart failure; LDL, low-density lipoprotein cholesterol; PAD, peripheral artery disease; T2D, Type 2 diabetes mellitus; TC, total cholesterol

Keywords: aaa, monocyte subsets, biomarker, cardiovascular, Surrogate marker

Received: 02 May 2025; Accepted: 07 Aug 2025.

Copyright: © 2025 Hamann, Klimova, Kapalla, Poitz, Busch, Morawietz, Reeps and Hofmann. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Anja Hofmann, Division of Vascular and Endovascular Surgery, Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Medical Faculty Carl Gustav Carus, Dresden, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.